Established in the mid 1970s, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics, and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including the development of molecular diagnostics, as well DNA and RNA vaccines. New England Biolabs is aPrivately held company, headquartered in Ipswich, MA, USA, and has extensive worldwide distribution through a network of exclusive distributors, agents and eight subsidiaries located in Australia, Canada, China, France, Germany, Japan, Singapore, and the UK
New England Biolabs
Unlock to Claim this listing
Add / Modify Company
4.41
Overall Excellence Rating
Industry
Pharmaceuticals & BiotechnologyCategory
Biotechnology ResearchESG/Ethical Impact
Environmental stewardship is one of the founding principles of NEB. By promoting sound ecological practices and environmental sustainability, NEB ensures the protection and preservation of natural resources, both locally and globally. We continuously strive for improvement in our business processes in order to minimize and, where possible, mitigate our impact on the environment. Raising awareness of our duty to the environment is paramount to NEB’s corporate message. As an additional measure of their commitment, NEB has received ISO 14001 certification, a quality standard for environmental management systems.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us

Awards Received
2023
Revenues
134700000
Website Traffic
Employee Rating
4.8
Customer Rating
4.9
Company Size
100-1000
ESG Risk Rating
3